Permeabilizing action of an antimicrobial lactoferricin-derived peptide on bacterial and artificial membranes

被引:45
作者
Aguilera, O
Ostolaza, H
Quirós, LM
Fierro, JF [1 ]
机构
[1] Sch Stomatol, Lab Oral Microbiol, Oviedo, Spain
[2] Univ Oviedo, Fac Med, Dept Funct Biol Microbiol, E-33006 Oviedo, Spain
[3] Univ Basque Country, EHU, UPV, CSIC,Unit Biophys, Bilbao 48080, Spain
[4] Univ Basque Country, Dept Biochem, Bilbao 48080, Spain
[5] Hosp Cent Asturias, Microbiol Serv, Asturias, Spain
关键词
lactoferricin; lactoferrin; liposome; antimicrobial peptide; Escherichia coli;
D O I
10.1016/S0014-5793(99)01545-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A synthetic peptide (23 residues) that includes the antibacterial and lipopolysaccharide-binding regions of human lactoferricin, an antimicrobial sequence of lactoferrin, was used to study its action on cytoplasmic membrane of Escherichia coli 0111 and E, coli phospholipid vesicles. The peptide caused a depolarization of the bacterial cytoplasmic membrane, loss of the pH gradient, and a bactericidal effect on E, coli, Similarly, the binding of the peptide to liposomes dissipated previously created transmembrane electrical and pH gradients. The dramatic consequences of the transmembrane ion flux during the peptide exposure indicate that the adverse effect on bacterial cells occurs at the bacterial inner membrane. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:273 / 277
页数:5
相关论文
共 26 条
[1]   LYSIS AND REASSEMBLY OF SONICATED LECITHIN VESICLES IN THE PRESENCE OF TRITON X-100 [J].
ALONSO, A ;
VILLENA, A ;
GONI, FM .
FEBS LETTERS, 1981, 123 (02) :200-204
[2]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[3]   ANTIBACTERIAL SPECTRUM OF LACTOFERRICIN-B, A POTENT BACTERICIDAL PEPTIDE DERIVED FROM THE N-TERMINAL REGION OF BOVINE LACTOFERRIN [J].
BELLAMY, W ;
TAKASE, M ;
WAKABAYASHI, H ;
KAWASE, K ;
TOMITA, M .
JOURNAL OF APPLIED BACTERIOLOGY, 1992, 73 (06) :472-479
[4]   IDENTIFICATION OF THE BACTERICIDAL DOMAIN OF LACTOFERRIN [J].
BELLAMY, W ;
TAKASE, M ;
YAMAUCHI, K ;
WAKABAYASHI, H ;
KAWASE, K ;
TOMITA, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1121 (1-2) :130-136
[5]  
BELLAMY WR, 1993, J APPL BACTERIOL, V75, P478
[6]  
BOULANGER P, 1988, J BIOL CHEM, V263, P9767
[7]   Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111 [J].
Chapple, DS ;
Mason, DJ ;
Joannou, CL ;
Odell, EW ;
Gant, V ;
Evans, RW .
INFECTION AND IMMUNITY, 1998, 66 (06) :2434-2440
[8]   EXPOSURE OF TRYPTOPHANYL RESIDUES IN PROTEINS - QUANTITATIVE-DETERMINATION BY FLUORESCENCE QUENCHING STUDIES [J].
EFTINK, MR ;
GHIRON, CA .
BIOCHEMISTRY, 1976, 15 (03) :672-680
[9]   Lactoferrin-lipopolysaccharide interaction: Involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide [J].
ElassRochard, E ;
Roseanu, A ;
Legrand, D ;
Trif, M ;
Salmon, V ;
Motas, C ;
Montreuil, J ;
Spik, G .
BIOCHEMICAL JOURNAL, 1995, 312 :839-845
[10]   MECHANISM OF ACTION OF THE PEPTIDE ANTIBIOTIC NISIN IN LIPOSOMES AND CYTOCHROME-C OXIDASE-CONTAINING PROTEOLIPOSOMES [J].
GAO, FH ;
ABEE, T ;
KONINGS, WN .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1991, 57 (08) :2164-2170